NDS Application, NDS Submission, Health Canada NDS, SNDS

Freyr provides Regulatory Affairs services to Innovator medicine product companies during NDS process with Health Canada, starting from pre-NDS meetings to submission of NDS/Market Notification and further Life Cycle Management (LCM) activities.
NDS (New Drug Submission) is a process through which new drugs are approved and controlled by the Canadian Health Authority before entering the Canadian market. In Canada, new drugs are regulated under Part C, Division 8 of Food and Drugs Regulations. The applicant will receive authorization to sell new drugs in Canada via NDS submission under Section C.08.002 of the Food and Drugs Regulations.

Leave a Reply

Your email address will not be published. Required fields are marked *